Author Archive

How Can Pharma Use Social Media In The Right Way?

Fedra Pavlou PharmTech Europe editorWe all know that the popularity of social media has sky rocketed, for the pharma industry, most notably within the last 12 months. Testament to this increase is the popularity of this blog, as well our LinkedIn group. I am proud to say that we now have 1,200 members of this group (and counting!) so it’s clear that people enjoy “meeting” and sharing ideas in this way. Don’t get me wrong, we’re still testing the water; trying to work out how best to use this new tool. Read more »

Paris: City of Romance, Culture and CPhI 2010!

Fedra Pavlou PharmTech Europe editorSo I’ve just returned from an exhausting but a fantastic week in Paris. The beautiful French capital played host to this year’s CPhI exhibition and whilst I didn’t get to take advantage of the cultural and architectural wonders that the city has to offer, I have to say that I came away with a real feeling of optimism (accompanied by a pair of very sore feet of course). Read more »

Pharma packs a punch

Fedra Pavlou PharmTech Europe editorI have just returned from an event in France which, I have to say, really impressed me. Not because I had the perfect excuse to visit Paris for a couple of days (although that was undoubtedly a bonus), but because I was so impressed by the calibre of presentations and new innovations that were showcased from this relatively small meeting. Read more »

European Regulators Take Action to Improve Public Information Access

Fedra Pavlou PharmTech Europe editorIn a news release issued by the European Organisation for Rare Diseases (EURORDIS) this week, the society commended the European Medicines Agency (EMEA) in its efforts to make the information that it has available on medicines more patient-friendly. Read more »

All Aboard the Twitter Bandwagon

Fedra Pavlou PharmTech Europe editorResistance to the social networking revolution has been particularly high amongst pharmaceutical industry professionals, though now it seems that more and more are coming round to the idea. Interestingly, it’s not only the pharma elite that are jumping on the bandwagon; so too are government agencies and, most notably, the FDA. Read more »

My Experience of Achema 2009

Fedra Pavlou PharmTech Europe editorThousands of people, enormous halls separated by mile-long walkways, huge machines promising to deliver efficient, cost-effective solutions, dancing jumpsuit wearers, superheroes, robots, and one pair of very sore feet. This is my first experience of Achema. Read more »